Although its introduction (together with other anti-tumor necrosis factor (TNF) medications) has majorly advanced psoriasis care, some patients experience persistent disease activity (primary non-responders), treatment failure over time (secondary non-responders), or side effects [3–5]. Here, TNF is linked to psoriasis.